BiotechTube

Laquinimod + Placebo

Phase 2Terminated
0 watching 0 views this week⚡ Active
49
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Relapsing Remitting Multiple Sclerosis

Conditions

Relapsing Remitting Multiple Sclerosis

Trial Timeline

Dec 7, 2005 → Jul 23, 2017

NCT ID
NCT00745615

About Laquinimod + Placebo

Laquinimod + Placebo is a phase 2 stage product being developed by Teva Pharmaceutical Industries for Relapsing Remitting Multiple Sclerosis. The current trial status is terminated. This product is registered under clinical trial identifier NCT00745615. Target conditions include Relapsing Remitting Multiple Sclerosis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
7
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT00745615Phase 2Terminated

Competing Products

20 competing products in Relapsing Remitting Multiple Sclerosis

See all competitors
ProductCompanyStageHype Score
Placebo + PirtobrutinibEli LillyPhase 2
52
CT-P53 + US-Ocrevus + EU-OcrevusCelltrionPhase 3
77
LY2127399 + PlaceboEli LillyPhase 2
52
dirucotide + placeboEli LillyPhase 2/3
65
BIIB019 (Daclizumab High Yield Process) + PlaceboAbbViePhase 2
52
DaclizumabAbbViePhase 3
77
BIIB019 (Daclizumab High Yield Process) + PlaceboAbbViePhase 2
52
BIIB019 (Daclizumab) + trivalent seasonal influenza vaccineAbbViePhase 2
52
BIIB019 (Daclizumab)AbbViePhase 3
77
BIIB019 (Daclizumab High Yield Process) + Interferon beta-1a Placebo + Interferon beta-1a + Daclizumab High Yield Process PlaceboAbbViePhase 3
77
Rebif (Interferon beta-1a)MerckPre-clinical
23
Interferon beta-1aMerckPre-clinical
23
Rebif New Formulation + prophylactic Ibuprofen + Rebif New Formulation + ibuprofen PRNMerckPhase 3
77
Rebif® + Avonex®MerckPhase 3
77
Rebif® + Rebif®MerckApproved
85
VigantOL oil plus interferon beta-1a (Rebif) + Placebo plus interferon beta-1a (Rebif) + Interferon beta-1a (Rebif®) aloneMerckPhase 2
52
Placebo + IFN beta-1a + MethylprednisoloneMerckPhase 2
52
Interferon beta-1a (Rebif)MerckApproved
85
Teriflunomide + EvobrutinibMerckPhase 3
77
Cladribine + Placebo + Microgynon®MerckPhase 1
33

Other Products from Teva Pharmaceutical Industries

TV-1106 + somatropinPhase 2
49
40 mg glatiramer acetate + PlaceboPhase 2
49
Hydroxychloroquine (HCQ) + Azithromycin (Azithro) + Placebo for Hydroxychloroquine + Placebo for AzithromycinPhase 2
49
cytarabine + omacetaxine mepesuccinate + decitabinePhase 2
49
Omacetaxine + Azacitidine + G-CSFPhase 1/2
38